The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update
Open accessAbstract
Interleukin-6 (IL-6) is a pleiotropic cytokine that not only regulates the immune and inflammatory response but also affects hematopoiesis, metabolism, and organ development. IL-6 can simultaneously elicit distinct or even contradictory physiopathological processes, which is likely discriminated by the cascades of signaling pathway, termed classic and trans-signaling. Besides playing several important physiological roles, dysregulated IL-6 has been demonstrated to underlie a number of autoimmune and inflammatory diseases, metabolic abnormalities, and malignancies. This review provides an overview of basic concept of IL-6 signaling pathway as well as the interplay between IL-6 and renal-resident cells, including podocytes, mesangial cells, endothelial cells, and tubular epithelial cells. Additionally, we summarize the roles of IL-6 in several renal diseases, such as IgA nephropathy, lupus nephritis, diabetic nephropathy, acute kidney injury, and chronic kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Abkhezr, M., & Dryer, S. E. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.092536 · Cited by 12
RetractedBettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · cited 1×
“Interleukin-6 (IL-6) was discovered in 1986 as a B cell stimulatory factor initiating IgG production (1).”
BackgroundImpaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768
An Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Role of oxidative stress in atherosclerosis
Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B., & Drexler, H. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03144-2 · Cited by 1,275
Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,135
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Rotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062
Griendling, K. K., Sorescu, D., Lassègue, B., & Ushio-Fukai, M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2175 · Cited by 955
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
Chomarat, P., Banchereau, J., Davoust, J., & Karolina Palucka, A. (2000) · Nature Immunology · doi:10.1038/82763 · Cited by 906
Lesina, M., Kurkowski, M. U., Ludes, K., Rose-John, S., Treiber, M., Klöppel, G., Yoshimura, A., Reindl, W., Sipos, B., Akira, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.009 · Cited by 862
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation
Kaplanski, G. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00013-3 · Cited by 811
Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells
Rincón, M., Anguita, J., Nakamura, T., Fikrig, E., & Flavell, R. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.461 · Cited by 810
Interleukin 6 and its receptor: ten years later
Hirano, T. (1998) · International Reviews of Immunology · doi:10.3109/08830189809042997 · Cited by 788
Soluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
Bruun, J. M., Lihn, A. S., Verdich, C., Pedersen, S. B., Toubro, S., Astrup, A., & Richelsen, B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00110.2003 · Cited by 775
EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition
中川, 学. (2014) · Institutional Repositories DataBase (IRDB) · Cited by 736
IL-6 signal transduction and its physiological roles: the signal orchestration model
Kamimura, D., Ishihara, K., & Hirano, T. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0012-2 · Cited by 673
Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K., & Hirano, T. (1996) · Immunity · doi:10.1016/s1074-7613(00)80501-4 · Cited by 652
Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
IL-6 and APPs: anti-inflammatory and immunosuppressive mediators
Tilg, H., Dinarello, C. A., & Mier, J. W. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01103-1 · Cited by 633
Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., & Hirano, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00734.x · Cited by 565
Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis
Linker-Israeli, M., Deans, R. J., Wallace, D. J., Prehn, J., Ozeri-Chen, T., & Klinenberg, J. R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.117 · Cited by 549
Tanaka, T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N., Fujiwara, H., Suematsu, S., Yoshida, N., & Kishimoto, T. (1995) · Cell · doi:10.1016/0092-8674(95)90418-2 · Cited by 528
IL-1 stimulates IL-6 production in endothelial cells.
Sironi, M., Breviario, F., Proserpio, P., Biondi, A., Vecchi, A., Van Damme, J., Dejana, E., & Mantovani, A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.549 · Cited by 521
The soluble interleukin‐6 receptor is generated by shedding
Mülberg, J., Schooltink, H., Stoyan, T., Günther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230226 · Cited by 506
Functional Analysis of the Domain Structure of Tumor Necrosis Factor-α Converting Enzyme
Reddy, P., Slack, J. L., Davis, R., Cerretti, D. P., Kozlosky, C. J., Blanton, R. A., Shows, D., Peschon, J. J., & Black, R. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14608 · Cited by 501
The role of interleukin-6 signaling in nervous tissue
Rothaug, M., Becker-Pauly, C., & Rose-John, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.018 · Cited by 491
Wassmann, S., Stumpf, M., Strehlow, K., Schmid, A., Schieffer, B., Böhm, M., & Nickenig, G. (2004) · Circulation Research · doi:10.1161/01.res.0000115557.25127.8d · Cited by 468
Associations between circulating inflammatory markers and residual renal function in CRF patients
Pecoits-Filho, R., Heimbürger, O., Bárány, P., Suliman, M., Fehrman-Ekholm, I., Lindholm, B., & Stenvinkel, P. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00353-6 · Cited by 448
Interleukin-6 Exacerbates Early Atherosclerosis in Mice
Huber, S. A., Sakkinen, P., Conze, D., Hardin, N., & Tracy, R. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2364 · Cited by 443
Soluble cytokine receptors are present in normal human urine.
Novick, D., Engelmann, H., Wallach, D., & Rubinstein, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1409 · Cited by 434
Plasticity and cross-talk of Interleukin 6-type cytokines
Garbers, C., Hermanns, H. M., Schaper, F., Müller-Newen, G., Grötzinger, J., Rose-John, S., & Scheller, J. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.001 · Cited by 400
IL-6/IL-6R Axis Plays a Critical Role in Acute Kidney Injury
Nechemia-Arbely, Y., Barkan, D., Pizov, G., Shriki, A., Rose-John, S., Galun, E., & Axelrod, J. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007070744 · Cited by 400
Matthews, V., Schuster, B., Schütze, S., Bussmeyer, I., Ludwig, A., Hundhausen, C., Sadowski, T., Saftig, P., Hartmann, D., Kallen, K.-J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210584200 · Cited by 390
Lagathu, C., Bastard, J.-P., Auclair, M., Maachi, M., Capeau, J., & Caron, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.013 · Cited by 385
Cytokine and cytokine receptor gene polymorphisms and their functionality
Smith, A. J. P., & Humphries, S. E. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.11.006 · Cited by 374 · cited 1×
“Apart from its involvement in LN, IL-6 gene polymorphism also conveys the susceptibility to cancer (142), lipid metabolic abnormalities, and inflammatory disorders (143).”
BackgroundThe IL-6/sIL-6R complex as a novel target for therapeutic approaches
Rose-John, S., Waetzig, G. H., Scheller, J., Grötzinger, J., & Seegert, D. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.5.613 · Cited by 360
Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G., Taga, T., & Kishimoto, T. (1993) · Blood · doi:10.1182/blood.v82.4.1120.1120 · Cited by 343
The Local and Systemic Inflammatory Transcriptome after Acute Kidney Injury
Grigoryev, D. N., Liu, M., Hassoun, H. T., Cheadle, C., Barnes, K. C., & Rabb, H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040469 · Cited by 334
Chalaris, A., Rabe, B., Paliga, K., Lange, H., Laskay, T., Fielding, C. A., Jones, S. A., Rose-John, S., & Scheller, J. (2007) · Blood · doi:10.1182/blood-2007-01-067918 · Cited by 329
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 316
Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
Dalla Vestra, M., Mussap, M., Gallina, P., Bruseghin, M., Cernigoi, A. M., Saller, A., Plebani, M., & Fioretto, P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110961 · Cited by 303
Interleukin-6 and its receptor: from bench to bedside
Scheller, J., & Rose-John, S. (2006) · Medical Microbiology and Immunology · doi:10.1007/s00430-006-0019-9 · Cited by 292
IL-6 Trans-Signaling Modulates TLR4-Dependent Inflammatory Responses via STAT3
Greenhill, C. J., Rose-John, S., Lissilaa, R., Ferlin, W., Ernst, M., Hertzog, P. J., Mansell, A., & Jenkins, B. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002971 · Cited by 264
Maladaptive Role of IL-6 in Ischemic Acute Renal Failure
Kielar, M. L., John, R., Bennett, M., Richardson, J. A., Shelton, J. M., Chen, L., Jeyarajah, D. R., Zhou, X. J., Zhou, H., Chiquett, B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2003090757 · Cited by 253
IL-6 rescues resting mouse T cells from apoptosis
Teague, T. K., Marrack, P., Kappler, J. W., & Vella, A. T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5791 · Cited by 248
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A. S., Jones, S. A., Rose-John, S., & Scheller, J. (2008) · Blood · doi:10.1182/blood-2007-07-102137 · Cited by 245
Dissection of Signaling Cascades through gp130 In Vivo
Ohtani, T., Ishihara, K., Atsumi, T., Nishida, K., Kaneko, Y., Miyata, T., Itoh, S., Narimatsu, M., Maeda, H., Fukada, T., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80162-4 · Cited by 243
Biswas, P., Delfanti, F., Bernasconi, S., Mengozzi, M., Cota, M., Polentarutti, N., Mantovani, A., Lazzarin, A., Sozzani, S., & Poli, G. (1998) · Blood · doi:10.1182/blood.v91.1.258 · Cited by 238
Dominitzki, S., Fantini, M. C., Neufert, C., Nikolaev, A., Galle, P. R., Scheller, J., Monteleone, G., Rose-John, S., Neurath, M. F., & Becker, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2041 · Cited by 227
Atsumi, T., Ishihara, K., Kamimura, D., Ikushima, H., Ohtani, T., Hirota, S., Kobayashi, H., Park, S.-J., Saeki, Y., Kitamura, Y., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020619 · Cited by 225 · cited 1×
“sIL-6R binds to IL-6 with comparable affinity as the mbIL-6R (21); consequently, the complex of IL-6/sIL-6R can activate gp130, a membrane protein is ubiquitously expressed (22–25).”
BackgroundNavarro, J. F., Milena, F. J., Mora, C., León, C., & García, J. (2006) · American Journal of Nephrology · doi:10.1159/000098004 · Cited by 220
Yamanaka, Y., Nakajima, K., Fukada, T., Hibi, M., & Hirano, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00500.x · Cited by 211
Matsumoto, S., Hara, T., Mitsuyama, K., Yamamoto, M., Tsuruta, O., Sata, M., Scheller, J., Rose-John, S., Kado, S.-I., & Takada, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0801217 · Cited by 211
IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
Lo, C.-W., Chen, M.-W., Hsiao, M., Wang, S., Chen, C.-A., Hsiao, S.-M., Chang, J.-S., Lai, T.-C., Rose-John, S., Kuo, M.-L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1496 · Cited by 193
IL-6 Deficiency Protects Against Angiotensin II–Induced Endothelial Dysfunction and Hypertrophy
Schrader, L. I., Kinzenbaw, D. A., Johnson, A. W., Faraci, F. M., & Didion, S. P. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.153080 · Cited by 184
Inflammatory signals associated with hemodialysis
Caglar, K., Peng, Y., Pupim, L. B., Flakoll, P. J., Levenhagen, D., Hakim, R. M., & Ikizler, T. A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00556.x · Cited by 181
IL-6 Modulates CD5 Expression in B Cells from Patients with Lupus by Regulating DNA Methylation
Garaud, S., Le Dantec, C., Jousse-Joulin, S., Hanrotel-Saliou, C., Saraux, A., Mageed, R. A., Youinou, P., & Renaudineau, Y. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802412 · Cited by 175
Schumacher, N., Meyer, D., Mauermann, A., von der Heyde, J., Wolf, J., Schwarz, J., Knittler, K., Murphy, G., Michalek, M., Garbers, C., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.649509 · Cited by 175
Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy
Sanchez-Niño, M.-D., Bozic, M., Córdoba-Lanús, E., Valcheva, P., Gracia, O., Ibarz, M., Fernandez, E., Navarro-Gonzalez, J. F., Ortiz, A., & Valdivielso, J. M. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00090.2011 · Cited by 171
Lemay, S., Rabb, H., Postler, G., & Singh, A. K. (2000) · Transplantation · doi:10.1097/00007890-200003150-00049 · Cited by 161
Cash, H., Relle, M., Weinmann‐Menke, J., Brochhausen, C., Jones, S. A., Topley, N., Galle, P. R., & Schwarting, A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090194 · Cited by 161
Fujimoto, M., Nakano, M., Terabe, F., Kawahata, H., Ohkawara, T., Han, Y., Ripley, B., Serada, S., Nishikawa, T., Kimura, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903314 · Cited by 160
Direct effects of dexamethasone on human podocytes
Xing, C.-Y., Saleem, M. A., Coward, R. J., Ni, L., Witherden, I. R., & Mathieson, P. W. (2006) · Kidney International · doi:10.1038/sj.ki.5001655 · Cited by 159
Gómez‐Guerrero, C., López-Armada, M. J., González, E., & Egido, J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.5247 · Cited by 150
Ebihara, N., Matsuda, A., Nakamura, S., Matsuda, H., & Murakami, A. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-7956 · Cited by 147
Signals that influence T follicular helper cell differentiation and function
Linterman, M. A., & Vinuesa, C. G. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0194-z · Cited by 145
Moura, I. C., Arcos‐Fajardo, M., Gdoura, A., Leroy, V. A. A., Sadaka, C., Mahlaoui, N., Lepelletier, Y., Vrtovsnik, F., Haddad, É., Benhamou, M., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004111006 · Cited by 128
Galil, S. M. A., Ezzeldin, N., & El‐Boshy, M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.007 · Cited by 127
Interleukin-6 as a Therapeutic Target in Candidate Inflammatory Diseases
Nishimoto, N. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.313 · Cited by 125
STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice
Mitsuyama, K., Matsumoto, S., Rose-John, S., Suzuki, A., Hara, T., Tomiyasu, N., Handa, K., Tsuruta, O., Funabashi, H., Scheller, J., et al. (2006) · Gut · doi:10.1136/gut.2005.079343 · Cited by 123
Differential shedding of the two subunits of the interleukin‐6 receptor
Müllberg, J., Dittrich, E., Graeve, L., Gerhartz, C., Yasukawa, K., Taga, T., Kishimoto, T., Heinrich, P. C., & Rose‐John, S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80507-q · Cited by 118
Kaur, H., Chien, A., & Jialal, I. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00319.2012 · Cited by 117
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy
Lu, T.-C., Wang, Z., Feng, X., Chuang, P. Y., Fang, W. Y., Shen, Y., Levy, D. E., Xiong, H., Chen, N., & He, C. (2009) · Kidney International · doi:10.1038/ki.2009.98 · Cited by 116
Sleep enhances IL‐6 trans‐signaling in humans
Dimitrov, S., Lange, T., Benedict, C., Nowell, M. A., Jones, S. A., Scheller, J., Rose‐John, S., Born, J., Dimitrov, S., Lange, T., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5754fje · Cited by 115
Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor
Orlando, S., Sironi, M., Bianchi, G., Drummond, A. H., Boraschi, D., Yabes, D., & Mantovani, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31764 · Cited by 114
Tamouza, H., Chemouny, J., Kafkova, L. R., Berthelot, L., Flamant, M., Demion, M., Mesnard, L., Paubelle, É., Walker, F., Julian, B. A., et al. (2012) · Kidney International · doi:10.1038/ki.2012.192 · Cited by 113
Serum and urinary interleukin-6 in systemic lupus erythematosus
Peterson, E. L., Robertson, A., & Emlen, W. (1996) · Lupus · doi:10.1177/096120339600500603 · Cited by 108
Richards, C. D., Langdon, C. M., Deschamps, P. A., Pennica, D., & Shaughnessy, S. G. (2000) · Cytokine · doi:10.1006/cyto.1999.0635 · Cited by 104
Oberg, H., Wesch, D., Grüssel, S., Rose‐John, S., & Kabelitz, D. (2006) · International Immunology · doi:10.1093/intimm/dxh396 · Cited by 103
Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide.
Walev, I., Vollmer, P., Palmer, M., Bhakdi, S., & Rose‐John, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7882 · Cited by 102
Urinary levels of IL-6 in patients with active lupus nephritis.
Iwano, M., Dohi, K., Hirata, E., Kurumatani, N., Horii, Y., Shiiki, H., Fukatsu, A., Matsuda, T., Hirano, T., & Kishimoto, T. (1993) · PubMed · Cited by 101
Kimura, A., & Kishimoto, T. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.10.004 · Cited by 100
Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells
Mitani, H., Katayama, N., Araki, H., Ohishi, K., Kobayashi, K., Suzuki, H., Nishii, K., Masuya, M., Yasukawa, K., Minami, N., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02020.x · Cited by 99
Gürr, W., Yavari, R., Li, W., Shaw, M., Mora, C., Christa, L., & Sherwin, R. S. (2002) · Diabetes · doi:10.2337/diabetes.51.2.339 · Cited by 96
Krishnaraju, K., Hoffman‐Liebermann, B., & Liebermann, D. A. (1998) · Blood · doi:10.1182/blood.v92.6.1957 · Cited by 96
Hitting a complex target: an update on interleukin-6 trans-signalling
Waetzig, G. H., & Rose‐John, S. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.660307 · Cited by 93
ADAM17-mediated shedding of the IL6R induces cleavage of the membrane stub by γ-secretase
Chalaris, A., Gewiese, J., Paliga, K., Fleig, L., Schneede, A., Krieger, K., Rose‐John, S., & Scheller, J. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.12.001 · Cited by 92
Reduction of Stat3 Activity Attenuates HIV-Induced Kidney Injury
Feng, X., Lu, T.-C., Chuang, P. Y., Fang, W. Y., Ratnam, K. K., Xiong, H., Ouyang, X., Shen, Y., Levy, D. E., Hyink, D. P., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080879 · Cited by 82
Srivastava, T., Sharma, M., Yew, K.-H., Sharma, R., Duncan, R. S., Saleem, M. A., McCarthy, E. T., Kats, A., Cudmore, P. A., Alon, U. S., et al. (2012) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-012-0184-0 · Cited by 80
Anderson, M., Roshanravan, H., Khine, J., & Dryer, S. E. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24461 · Cited by 77
Ball, E., Gibson, D. S., Bell, A., & Rooney, M. (2013) · Lupus · doi:10.1177/0961203313512882 · Cited by 71
Ranganathan, P. V., Jayakumar, C., & Ramesh, G. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00650.2012 · Cited by 70
Yoshino, J., Monkawa, T., Tsuji, M., Hayashi, M., & Saruta, T. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000101180.96787.02 · Cited by 70
Tanaka, M., Kishimura, M., Ozaki, S., Osakada, F., Hashimoto, H., Okubo, M., Murakami, M., & Nakao, K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7479 · Cited by 69
Vardam, T. D., Zhou, L., Appenheimer, M. M., Chen, Q., Wang, W.-C., Baumann, H., & Evans, S. S. (2007) · Cytokine · doi:10.1016/j.cyto.2007.07.184 · Cited by 67
Dai, Y., Gu, L., Yuan, W., Yu, Q., Ni, Z., Ross, M. J., Kaufman, L., Xiong, H., Salant, D. J., He, C., et al. (2013) · Kidney International · doi:10.1038/ki.2013.197 · Cited by 67
Aerobic capacity and skeletal muscle properties of normoxic and hypoxic rats in response to training
Abdelmalki, A., Fimbel, S., Mayet, M. H., SEMPORE, B., & Favier, R. J. M. (1996) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf02253829 · Cited by 67
No inhibition of IL-27 signaling by soluble gp130
Scheller, J., Schuster, B., Hölscher, C., Yoshimoto, T., & Rose‐John, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.098 · Cited by 66
Andriankaja, O. M., Barros, S. P., MOSS, K. L., Panagakos, F. S., DeVizio, W., Beck, J. D., & Offenbacher, S. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.080385 · Cited by 66
Finotto, S., Eigenbrod, T., Karwot, R., Boross, I., Doganci, A., Ito, H., Nishimoto, N., Yoshizaki, K., Kishimoto, T., Rose‐John, S., et al. (2007) · International Immunology · doi:10.1093/intimm/dxm037 · Cited by 65
Arakawa, T., Masaki, T., Hirai, T., Doi, S., Kuratsune, M., Arihiro, K., Kohno, N., & Yorioka, N. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn314 · Cited by 64
Zhang, J., Li, Y., Shan, K., Wang, L., Qiu, W., Lu, Y., Zhao, D., Zhu, G., He, F., & Wang, Y. (2013) · The FASEB Journal · doi:10.1096/fj.13-242693 · Cited by 63
Zhang, J., Zhang, Y., Owczarek, C. M., Ward, L. D., Moritz, R. L., Simpson, R. J., Yasukawa, K., & Nicola, N. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10798 · Cited by 63
Schmitt, R., Ståhl, A.-L., Olin, A. I., Kristoffersson, A., Rebetz, J., Novák, J., Lindahl, G., & Karpman, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302249 · Cited by 63
Updating interleukin‐6 classic‐ and trans‐signaling
Scheller, J., Grötzinger, J., & Rose‐John, S. (2006) · Signal Transduction · doi:10.1002/sita.200600086 · Cited by 61
Tanaka, H., Matsumura, I., Nakajima, K., Daino, H., Sonoyama, J., Yoshida, H., Oritani, K., Machii, T., Yamamoto, M. P., Hirano, T., et al. (2000) · Blood · doi:10.1182/blood.v95.4.1264.004k09_1264_1273 · Cited by 60
IL-6 and the acute phase response in murine atherosclerosis
Song, L., & Schindler, C. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.06.018 · Cited by 59
Franchimont, N., Lambert, C., Huynen, P., Ribbens, C., Relić, B., Chariot, A., Bours, V., Piette, J. G., Merville, M., & Malaise, M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20727 · Cited by 58
Solus, J. F., Chung, C. P., Oeser, A. M., Li, C., Rho, Y. H., Bradley, K. M., Kawai, V. K., Smith, J. R., & Stein, C. M. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-2881-6 · Cited by 58
Interleukin‐6 Trans‐Signaling Exacerbates Inflammation and Renal Pathology in Lupus‐Prone Mice
Tsantikos, E., Maxwell, M. J., Putoczki, T. L., Ernst, M., Rose‐John, S., Tarlinton, D. M., & Hibbs, M. L. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38061 · Cited by 56
Selective Induction of MCP-1 in Human Mesangial Cells by the IL-6/sIL-6R Complex
Coletta, I., Soldo, L., Polentarutti, N., Mancini, F., Guglielmotti, A., Pinza, M., Mantovani, A., & Milanese, C. (2000) · Nephron Experimental Nephrology · doi:10.1159/000059327 · Cited by 50
Kuravi, S. J., McGettrick, H. M., Satchell, S. C., Saleem, M. A., Harper, L., Williams, J. M., Rainger, G. E., & Savage, C. O. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300229 · Cited by 50
Peters, M. J., Odenthal, M., Schirmacher, P., Blessing, M., Fattori, E., Ciliberto, G., Büschenfelde, K. H. M. Z., & Rose‐John, S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1474 · Cited by 48
Jasiewicz, M., Knapp, M., Waszkiewicz, E., Ptaszyńska‐Kopczyńska, K., Szpakowicz, A., Sobkowicz, B., Musial, W. J., & Kamiński, K. A. (2015) · Cytokine · doi:10.1016/j.cyto.2015.06.018 · Cited by 44
Interleukin-11: Biological Activity and Clinical Studies
Dorner, A. J., Goldman, S. J., & Keith, J. C. (1997) · BioDrugs · doi:10.2165/00063030-199708060-00002 · Cited by 41
Velásquez, I. M., Golabkesh, Z., Källberg, H., Leander, K., Fairé, U. D., & Gigante, B. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.014 · Cited by 39
Malchow, S., Thaiss, W. M., Jänner, N., Waetzig, G. H., Gewiese, J., Garbers, C., Yamamoto, K., Rose‐John, S., & Scheller, J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.11.009 · Cited by 39
Kim, D., & Park, S. H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.046 · Cited by 38
Pfäfflin, A., Brodbeck, K., Heilig, C., Häring, H. U., Schleicher, E. D., & Weigert, C. (2006) · Cellular Physiology and Biochemistry · doi:10.1159/000097667 · Cited by 37
Lee, S. J., Borsting, E., Declèves, A., Singh, P., & Cunard, R. A. (2012) · Nephron Experimental Nephrology · doi:10.1159/000345151 · Cited by 36
Yoshida, H., Hashizume, M., Suzuki, M., & Mihara, M. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.026 · Cited by 35
Li, H., Rokavec, M., & Hermeking, H. (2015) · Oncotarget · doi:10.18632/oncotarget.4334 · Cited by 31
Santos, M. J., Carmona-Fernandes, D., Capela, S., da Silva, J. C., & Fonseca, J. E. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1640-y · Cited by 30
Association between IL6 -174G/C and cancer: A meta-analysis of 105,482 individuals
Liu, R., Song, X., Chen, P., Lei, Z., Miao, J., Yi, N., Zhang, K., Pasche, B., & Zhang, H. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.454 · Cited by 28
Vahdat, A. M., Reiners, K. S., Simhadri, V. L., Eichenauer, D. A., Böll, B., Chalaris, A., Simhadri, V. R., Wiegmann, K., Krell, H. W., Rose‐John, S., et al. (2009) · Leukemia · doi:10.1038/leu.2009.230 · Cited by 28
Papaoikonomou, S., Tentolouris, N., Tousoulis, D., Papadodiannis, D., Miliou, A., Παπαγεωργίου, Ν., Hatzis, G., & Stefanadis, C. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.06.006 · Cited by 28
Regulation of IL-6-type cytokine responses by MAPKs
Costa‐Pereira, A. P. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130267 · Cited by 27
Lee, Y. H., Lee, Y. H., Choi, S., Ji, J., & Song, G. G. (2011) · Lupus · doi:10.1177/0961203311422711 · Cited by 26
Lamas, J. R., Rodríguez‐Rodríguez, L., Tornero-Esteban, P., Villafuertes, E., Hoyas, J. A., Abásolo, L., Varadé, J., Álvarez‐Lafuente, R., Urcelay, E., & Fernández‐Gutiérrez, B. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.025 · Cited by 24
Matsumoto, T., Hess, S. Y., Kajiyama, H., Sakairi, T., Saleem, M. A., Mathieson, P. W., Nojima, Y., & Kopp, J. B. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00597.2009 · Cited by 20
Zhuang, P., Wang, J., Tang, Z., Zhou, X.-P., Quan, Z.-W., Liu, Y., & Shen, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1763-2 · Cited by 19
SOLUBLE GLYCOPROTEIN 130 (gp130) ATTENUATES OSM- AND LIF-INDUCED CARTILAGE PROTEOGLYCAN CATABOLISM
Wang, H., Bell, M., & Carroll, G. J. (2000) · Cytokine · doi:10.1006/cyto.1999.0550 · Cited by 13
Obesity‐induced renal impairment is exacerbated in interleukin‐6‐knockout mice
Harcourt, B. E., Forbes, J. M., & Matthews, V. B. (2011) · Nephrology · doi:10.1111/j.1440-1797.2011.01547.x · Cited by 9
Cited by
Zhang, C., Wu, Z., Li, J.-W., Zhao, H., & Wang, G.-Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105954 · Cited by 1,758
Self-citationInterleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Ridker, P. M., & Rane, M. (2021) · Circulation Research · doi:10.1161/circresaha.121.319077 · Cited by 691
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Weiskirchen, R., Weiskirchen, S., & Tacke, F. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.003 · Cited by 538
Acute kidney injury in critically ill patients with COVID-19
Gabarre, P., Dumas, G., Dupont, T., Darmon, M., Azoulay, E., & Zafrani, L. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06153-9 · Cited by 529
Immunomodulation by endothelial cells — partnering up with the immune system?
Amersfoort, J., Eelen, G., & Carmeliet, P. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00694-4 · Cited by 525
Metadata
- Authors
- Su, H., Lei, C.-T., & Zhang, C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-04-21
- Volume
- 8
- Pages
- 405-405
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2608591750
- Cited by
- 524
- References
- 144
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.